News

INC Research announces its involvement in the Leukemia & Lymphoma Society’s (LLS) precision medicine Master Trial for the treatment of acute myeloid leukemia (AML).

In 2014, EU Regulation n.536/2014 represented a significant step toward transparency of clinical trials in Europe. However, despite the EMA’s policy 0070, which reinforced this concept, several aspects remain to be determined or evaluated, leaving room for additional requirements and local interpretation.

Centralized monitoring is a suitable way in which sites can identify and control investigational risks while improving performance. This new approach can not only help sponsors to monitor site performance, but also facilitate proper oversight resulting in good ROI.

eClinicalHealth Limited announced a partnership with Clinerion to offer a readiness certification to 27.5 million potential study candidates at hospitals in Turkey.

EUPATI celebrates its 5th Anniversary in Brussels by staging a free workshop.

The Drug Information Association (DIA) has released a video to introduce the two chairpersons of its 2017 EuroMeeting, to be held in Glasgow, U.K., from March 29-31

With pursuits in rare and orphan disease beginning to move more into the drug development mainstream, the opportunities and challenges in patient engagement and trial execution for these conditions are ever-evolving, as one strategy expert in the field discusses.

Medidata’s Clinical Cloud solution has been adopted by Japan’s Nobelpharma to power a clinical trial on sleep disorders in children with neurodevelopmental disabilities.

Schulman IRB will launch its new Central Oncology Review (COR) division this month.

FDA officials agree that large comparative clinical trials defeat the purpose of the abbreviated development program for biosimilars. Clinical testing is expected to gain market approval for most biosimilars, while emphasizing significant differences in developing biosimilars and innovator therapies.

The pharma and aerospace industries share similarities whereas both are highly regulated, risk adverse and fast-paced markets. However, if there’s one thing that pharma companies can learn from the aerospace industry, it’s their approach to operations.

CluePoints, a provider of RBM and CSM solutions for clinical trials, announced a new Data Quality Oversight service, RADAR.

KMR Group recently conducted its annual Clinical Trial Cycle Time Report.

Worldwide Clinical Trials has received findings from a recent global survey that evaluated preferences of investigators who participated in CNS studies that employ rater training and surveillance methodologies.

ICON plc announces that it has chosen TriNetX as its platform for accessing Electronic Medical Record (EMR) systems.

The new Research Activity League Table from the NIHR Clinical Research Network shows all NHS trusts or hospital groups in England are delivering clinical research and over 60% increased their research activity last year.

Q2 Solutions, a global clinical trials laboratory services organization, has come to an agreement with Illumina, a global genomics provider.

The FDA’s launch of patient centric initiatives has led the industry to gear towards incorporating the patient’s voice in medical product development. Tom Krohn of Antidote discusses his company’s patient centered approach towards clinical trial matching by focusing on the patient.

SCRS has announced the release of the Common Language Evaluation and Reconciliation (CLEAR) contract clauses for clinical research site contracts in North America.